Why is Brooks Lab. falling/rising?

As of 21-Jul, Brooks Laboratories Ltd is experiencing a price increase, currently at 159.70, reflecting a rise of 3.1 or 1.98%. The stock has shown strong performance today, outperforming its sector by 2.3%. It has been highly volatile with an intraday volatility of 332.79%. Additionally, Brooks Laboratories is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock has also seen a significant increase in investor participation, with delivery volume rising by 97.78% compared to the 5-day average. Over the past week, the stock has gained 5.76%, and it has delivered an impressive 88.10% return over the last year, outperforming the BSE500 index.
In the broader market context, while Brooks Laboratories has shown strong short-term returns, the benchmark Sensex has remained relatively flat with a change of -0.06% over the same period. Despite the positive short-term performance, there are concerns regarding the company's long-term fundamentals, including a weak average Return on Equity (ROE) of 0% and a negative EBIT to Interest ratio of -4.50. Although the stock has generated substantial returns over the past year, its long-term growth has been hindered by a decline in net sales at an annual rate of -2.90% over the last five years. These mixed signals suggest that while the stock is currently rising, underlying weaknesses may pose challenges in sustaining this momentum.